SM Domchek, A Antoniou - Annals of Internal Medicine, 2007 - Am Coll Physicians B RCA1 and BRCA2 mutation carriers have a very high lifetime risk for breast or ovarian
cancer. Because strat- egies to reduce these risks are effective (1), identifying ap- propriate individuals
for genetic testing is very important. During genetic counseling, a professional obtains a ... Related articles - BL Direct - All 2 versions
- ►vcu.edu [PDF] JM Quillin, V Ramakrishnan, J Borzelleca, J … - American journal of …, 2006 - Elsevier Reported family medical history may be the most widely accessible genomics screen currently
available. The worth of any population-screening tool may be measured by parameters such
as sensitivity and specificity. There is some evidence and theory suggesting that family ... Cited by 12 - Related articles - All 11 versions
J Diffey, A Hufton, S Astley, C Mercer, A Maxwell - Proceedings of the 9th …, 2008 - Springer 1 North Western Medical Physics, Christie Hospital, Withington, Manchester M20 4BX
jenny.diffey@physics.cr.man.ac.uk 2 Division of Imaging Science and Biomedical
Engineering, Stopford Building, University of Manchester, Oxford Road, Manchester M13 ... Related articles - All 2 versions
- ►ascopubs.org [PDF] E Amir, O Freedman - Journal of Clinical Oncology, 2009 - jco.ascopubs.org REFERENCES 1. Meyerhardt JA, Niedzwiecki D, Hollis D, et al: Impact of body mass index and
weight change after treatment on cancer recurrence and survival in patients with stage III colon
cancer: Findings from Cancer and Leukemia Group B 89803. J Clin Oncol 26:4109-4115, ... Related articles - All 4 versions
- ►prsjournal.com AC Antoniou, R Hardy, L Walker, DG Evans, A … - British Medical …, 2008 - jmg.bmj.com Objectives: Genetic testing for the breast and ovarian cancer susceptibility genes BRCA1 and
BRCA2 has important implications for the clinical management of people found to carry a
mutation. However, genetic testing is expensive and may be associated with adverse ... Cited by 11 - Related articles - All 6 versions
[CITATION] Genetic Counseling for Hereditary Tumors
PO Chappuis - Revue médicale suisse, 2006 - titan.medhyg.ch L'un des principaux facteurs de risque du cancer du sein est la présence d'antécédents familiaux
de cette affection. Une anamnèse familiale détaillée permet, d'une part, d'évaluer le risque de
développer un cancer du sein, et, d'autre part, de préciser la probabilité de l'existence ... Related articles - Cached - BL Direct - All 2 versions
KM Field, M Croxford, I Hastie, F Chen, S … - Journal of Clinical …, 2009 - jco.ascopubs.org TO THE EDITOR:Drs Lorenz and Ganz1 brought together a stellar group of investigators providing
a comprehensive review on quality of care and supportive care in oncology. I commend the authors
for stating up front that an examination of quality of care in oncology needs to include not ... Related articles - All 5 versions
J Cuzick, DM Eccles, A Howell, M Harvie, RJ … - Breast Cancer …, 2008 - biomedcentral.com Risk factors for breast cancer can be allocated to one of four major groups: family
history/genetic, reproductive/hormonal, proliferative benign breast disease and mammographic
density. These four factors have now been thoroughly studied, and accurate quantitative ... Related articles - View as HTML - All 5 versions
B Drohan, G Grinstein - doi.ieeecomputersociety.org Clinicians have a traditional set of visualization tools that are used to help identify patients whose
family may have a genetic cancer susceptibility syndrome. Although there is often some level
of combined utility, the visualization tools used by clinicians are often distinct from those ... Related articles
